Replies to post #70614 on NanoViricides Inc. (NNVC)

[changes_iv]

The time from Phase II to market is often shorter for orphan drugs due to shorter and smaller clinical trials and FDA Fast Track designation.

I'll go with a "...few short months..." as Dr. Seymour says...4Q 2014.